Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.73%12.12B | 22.94%2.96B | 21.38%2.73B | 25.05%9.87B | 17.21%2.65B | 21.10%2.57B | 27.21%2.4B | 38.65%2.25B | 31.15%7.89B | 39.77%2.26B |
| Cost of revenue | 25.85%10B | 32.28%2.53B | 29.98%2.27B | 25.90%7.95B | 29.90%2.27B | 20.13%2.01B | 26.86%1.92B | 26.78%1.75B | 28.84%6.31B | 33.91%1.75B |
| Gross profit | 9.81%2.11B | -13.69%421.71M | -8.97%451.11M | 21.67%1.92B | -26.03%379.25M | 24.71%560.09M | 28.63%488.61M | 107.11%495.56M | 41.28%1.58B | 64.30%512.72M |
| Operating expense | 28.98%825.26M | 45.03%191.76M | 5.22%183.07M | 2.92%639.81M | 15.44%166.7M | 1.67%166.89M | -22.31%132.23M | 21.77%173.99M | 19.35%621.64M | 26.35%144.41M |
| Staff costs | 2.39%242.89M | 5.31%59.26M | -1.17%59.45M | 4.59%237.22M | 2.31%59.91M | -0.70%60.89M | -0.00%56.27M | 18.74%60.16M | 6.14%226.79M | 21.82%58.55M |
| Depreciation and amortization | 0.00%61.37M | 0.00%15.34M | 0.00%15.34M | 2.29%61.37M | -0.01%15.34M | 0.01%15.34M | 0.00%15.34M | 9.83%15.34M | 7.37%59.99M | 9.84%15.34M |
| -Depreciation | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Amortization | 0.00%61.37M | 0.00%15.34M | 0.00%15.34M | 2.29%61.37M | -0.01%15.34M | 0.01%15.34M | 0.00%15.34M | 9.83%15.34M | 7.37%59.99M | 9.84%15.34M |
| Other operating expenses | 52.68%521.01M | 93.28%117.17M | 9.93%108.27M | 1.91%341.23M | 29.69%91.46M | 3.62%90.67M | -38.51%60.62M | 25.87%98.49M | 33.25%334.85M | 34.93%70.52M |
| Operating profit | 0.25%1.29B | -35.48%229.94M | -16.65%268.04M | 33.81%1.28B | -42.29%212.55M | 37.99%393.19M | 69.97%356.39M | 233.62%321.57M | 60.37%959.32M | 86.23%368.31M |
| Net non-operating interest income (expenses) | -23.04%-431.33M | -29.06%-108.44M | -32.39%-103.7M | -23.93%-350.57M | -26.61%-95.33M | -26.86%-92.89M | -14.26%-84.02M | -28.77%-78.33M | -37.39%-282.88M | -32.79%-75.29M |
| Non-operating interest income | 1,370.59%250K | --10K | 28.57%9K | 30.77%17K | --0 | 25.00%10K | --0 | 40.00%7K | 44.44%13K | --0 |
| Non-operating interest expense | 23.10%431.58M | 29.07%108.45M | 32.39%103.71M | 23.93%350.59M | 26.61%95.33M | 26.86%92.9M | 14.26%84.02M | 28.77%78.34M | 37.39%282.89M | 32.79%75.29M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 1.43M | 0 | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.43M | --0 |
| Other non-operating income (expenses) | 60.09%152.42M | 1,247.50%3.23M | 277.47%81.78M | -10.57%95.21M | 169.07%72.32M | 421.90%985K | 35.59%240K | -72.82%21.67M | 322.41%106.46M | 739.14%26.88M |
| Income before tax | -1.98%1.01B | -54.24%124.74M | -7.09%246.12M | 31.11%1.03B | -40.75%189.55M | 42.51%301.29M | 99.97%272.6M | 127.00%264.9M | 87.87%784.33M | 133.73%319.9M |
| Income tax | 6.33%368.39M | -36.69%51.77M | -6.25%94.07M | 13.38%346.45M | -43.56%66.56M | 17.48%97.79M | 38.60%81.77M | 120.94%100.34M | 72.95%305.58M | 95.84%117.93M |
| Net income | -6.20%639.58M | -61.76%72.97M | -7.60%152.04M | 42.43%681.88M | -39.10%122.99M | 58.77%203.5M | 146.79%190.83M | 130.86%164.56M | 98.81%478.75M | 163.51%201.97M |
| Net income continuous operations | -6.20%639.58M | -61.76%72.97M | -7.61%152.04M | 42.43%681.88M | -39.10%122.99M | 58.77%203.5M | 146.79%190.83M | 130.87%164.56M | 98.81%478.75M | 163.51%201.97M |
| Noncontrolling interests | 24.02M | 7.51M | ||||||||
| Net income attributable to the company | -6.20%639.58M | -61.76%72.97M | -7.60%152.04M | 49.95%681.88M | -36.75%122.99M | 69.57%203.5M | 176.64%190.83M | 130.86%164.56M | 88.84%454.73M | 153.71%194.46M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -6.20%639.58M | -61.76%72.97M | -7.60%152.04M | 49.95%681.88M | -36.75%122.99M | 69.57%203.5M | 176.64%190.83M | 130.86%164.56M | 88.84%454.73M | 153.71%194.46M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -8.09%77.95 | -62.89%8.81 | -8.60%18.71 | 49.50%84.81 | -36.99%15.28 | 69.03%25.32 | 175.73%23.74 | 130.26%20.47 | 87.35%56.73 | 152.34%24.25 |
| Diluted earnings per share | -9.58%76.19 | -63.15%8.69 | -10.87%18.12 | 49.74%84.26 | -36.80%15.2 | 69.25%25.15 | 175.79%23.58 | 130.76%20.33 | 88.57%56.27 | 153.42%24.05 |
| Dividend per share | 15 | |||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |